Les Sulewski's Stock Ratings

Truist Securities Analyst

Les Sulewski is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 09/07/2024

Overall Average Return

-9.26%

Smart Score

42.8%

Overall Average Return Percentile

21st

Number of Ratings

7
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

The Analyst Landscape: 4 Takes On Collegium Pharmaceutical
Where Pacira BioSciences Stands With Analysts
The Analyst Verdict: Collegium Pharmaceutical In The Eyes Of 4 Experts
Expert Ratings For Pacira BioSciences
Demystifying Collegium Pharmaceutical: Insights From 4 Analyst Reviews
Assessing Amneal Pharmaceuticals: Insights From 4 Financial Analysts
Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know
What More Can Support Biogen/Sage's Zuranolone Resubmission: Analysts See Uncertain Road Ahead
The FDA approved Sage Therapeutics Inc (NASDAQ: SAGE) and Biogen Inc's (NASDAQ: BIIB) Zurzuvae (zuranolone) 50 mg for adults with postpartum depression (PPD) but issued a Complete Response Letter
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free